// App-Quantinova.ai

TCT-769 : Impact of embolic protection and repositioning on stroke in patients treated with a repositionable and fully retrievable aortic valve in routine clinical practice: An analysis from the RESPOND post-market study

Researchers

Presenter

  • Jochen Wohrle

Principal Investigators

  • David Hildick-Smith

  • Sabine Bleiziffer

  • Daniel Blackman

  • Mohamed Abdel-Wahab

  • Dominic Allocco

  • Ian Meredith

  • Volkmar Falk

  • Nicolas Van Mieghem

Medical Centers

  • University Hospital Ulm, Ulm, Germany

  • Deutsches Herzzentrum Berlin, Klinik für Herz-Thorax-Gefässchirurgie, Berlin, Germany

  • Royal Sussex County Hospital, Brighton, United Kingdom

  • Thorax Center, Erasmus Medical Center, Rotterdam, Netherlands

  • Heart Center, Segeberger Kliniken, Bad Segeberg, Germany

  • Leeds General Infirmary, Leeds, United Kingdom

  • Boston Scientific, Maple Grove, Minnesota, United States

  • German Heart Center Munich, Munich, Germany

Locations

  • Germany

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Cardiovascular (CVS)

Disease

  • Transient Ischemic Attack

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved